Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities

Br J Dermatol. 2014 Dec;171(6):1561-5. doi: 10.1111/bjd.13122. Epub 2014 Nov 20.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adalimumab
  • Adult
  • Aged
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Cost of Illness
  • Cross-Sectional Studies
  • Hidradenitis Suppurativa / complications*
  • Hidradenitis Suppurativa / drug therapy
  • Humans
  • Middle Aged
  • Risk Factors

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • Adalimumab